Table 3:
Changes of the Cx37 gene expressions in the control, PCOS, and POR groups
| Groups | CX37 2^−ΔΔC t | P-value1 | P-value2 | P-value3 | |||
|---|---|---|---|---|---|---|---|
|
| |||||||
| N | Mean | SD | Median | ||||
| Control (N without treatment) | 3 | 1.000 | 0.000 | 1.000 | |||
| Control (N- ISOP) | 3 | 0.641 | 0.058 | 0.653 | 0.037a | ||
| Control (N- Prop) | 3 | 0.901 | 0.035 | 0.905 | 0.037a | ||
| PCOS without treatment | 3 | 0.366 | 0.016 | 0.370 | 0.037a | ||
| PCOS-ISOP | 3 | 0.232 | 0.005 | 0.232 | 0.049b | 0.049 | |
| PCOS-Prop | 3 | 0.482 | 0.021 | 0.482 | 0.049c | 0.049 | |
| POR without treatment | 3 | 0.308 | 0.024 | 0.307 | 0.037a | ||
| POR-ISOP | 3 | 0.003 | 0.003 | 0.002 | 0.049b | 0.049 | |
| POR-Prop | 3 | 0.570 | 0.021 | 0.581 | 0.049c | 0.049 | |
P-value1: -a: In comparison with Non-PCOS without treatment group. b: In comparison with Control Isoproterenol group. c: In comparison with Non-PCOS Propranolol group.
P-value2: : In comparison with PCOs without treatment
P-value3: : In comparison with poor responder without treatment group
All comparison was done with Mann-Whitney test.